207 related articles for article (PubMed ID: 7888287)
1. Exercise metabolism in healthy volunteers taking atenolol, high and low doses of metoprolol CR/Z0K, and placebo.
Head A; Maxwell S; Kendall MJ; Eagles C
Br J Clin Pharmacol; 1994 Dec; 38(6):499-504. PubMed ID: 7888287
[TBL] [Abstract][Full Text] [Related]
2. The effects of combined treatment with beta 1-selective receptor antagonists and lipid-lowering drugs on fat metabolism and measures of fatigue during moderate intensity exercise: a placebo-controlled study in healthy subjects.
Eagles CJ; Kendall MJ
Br J Clin Pharmacol; 1997 Mar; 43(3):291-300. PubMed ID: 9088584
[TBL] [Abstract][Full Text] [Related]
3. Effects of a week's beta-adrenoceptor blockade with atenolol and metoprolol CR/ZOK on the response to exercise in healthy women aged 50 to 70 years.
Patrick J; Bassey J; Morrant J; Macdonald I
J Clin Pharmacol; 1990 Feb; 30(S2):S108-16. PubMed ID: 2312773
[TBL] [Abstract][Full Text] [Related]
4. Exercise metabolism in healthy volunteers taking celiprolol, atenolol, and placebo.
Head A; Maxwell S; Kendall MJ
Br J Sports Med; 1997 Jun; 31(2):120-5. PubMed ID: 9192124
[TBL] [Abstract][Full Text] [Related]
5. Pharmacokinetics and pharmacodynamics of controlled-release metoprolol: a comparison with atenolol.
Blomqvist I; Westergren G; Sandberg A; Jonsson UE; Lundborg P
Eur J Clin Pharmacol; 1988; 33 Suppl():S19-24. PubMed ID: 3371390
[TBL] [Abstract][Full Text] [Related]
6. Beta-adrenoceptor blockade and CNS-related subjective symptoms: a randomized, double-blind, placebo-controlled comparison of metoprolol CR/ZOK, atenolol and propranolol LA in healthy subjects.
Dimenäs E; Kerr D; Macdonald I
J Clin Pharmacol; 1990 Feb; 30(S2):S103-7. PubMed ID: 1968912
[TBL] [Abstract][Full Text] [Related]
7. Controlled-release metoprolol compared with atenolol in asthmatic patients: interaction with terbutaline.
Löfdahl CG; Dahlöf C; Westergren G; Olofsson B; Svedmyr N
Eur J Clin Pharmacol; 1988; 33 Suppl():S25-32. PubMed ID: 2836204
[TBL] [Abstract][Full Text] [Related]
8. Is metoprolol CR/ZOK more selective than conventional metoprolol and atenolol?
Kendall M; Akhlaghi S; Hughes B; Lewis H
J Clin Pharmacol; 1990 Feb; 30(S2):S98-102. PubMed ID: 2155948
[TBL] [Abstract][Full Text] [Related]
9. A double-blind comparison of once-daily metoprolol controlled-release and atenolol in the treatment of Chinese patients with mild to moderate hypertension.
Chen MF; Yang CY; Chen WJ; Lee CM; Wu CC; Liau CS; Lee YT
Cardiovasc Drugs Ther; 1995 Jun; 9(3):401-6. PubMed ID: 8527349
[TBL] [Abstract][Full Text] [Related]
10. Pharmacokinetic and pharmacodynamic properties of controlled release (CR/ZOK) metoprolol in healthy Oriental subjects: a comparison with conventional formulations of metoprolol and atenolol.
Darmansjah I; Wong E; Setiawati A; Moeloek D; Irawati D; Siagian M; Muchtar A
J Clin Pharmacol; 1990 Feb; 30(S2):S39-45. PubMed ID: 2312778
[TBL] [Abstract][Full Text] [Related]
11. Duration of beta-blockade with metoprolol and atenolol: influence of drug oxidation.
Freestone S; Lennard MS; Silas JH; Ramsay LE
Postgrad Med J; 1983; 59 Suppl 3():36-7. PubMed ID: 6647208
[TBL] [Abstract][Full Text] [Related]
12. Subjective symptoms and pharmacokinetics/dynamics of metoprolol CR in elderly subjects--a comparison with atenolol.
Dimenäs ES; Dahlöf CG; Heibel B; Moore RG; Olofsson BK; Westergren GE; Lücker PW
Eur J Clin Pharmacol; 1990; 38(6):571-8. PubMed ID: 2373131
[TBL] [Abstract][Full Text] [Related]
13. Effects on exercise tachycardia during forty-eight hours of a series of doses of atenolol, sotalol, and metoprolol.
Harron DW; Balnave K; Kinney CD; Wilson R; Russell CJ; Shanks RG
Clin Pharmacol Ther; 1981 Mar; 29(3):295-302. PubMed ID: 7471600
[TBL] [Abstract][Full Text] [Related]
14. Metabolic aspects of maximal exercise performance after slow release metoprolol and after atenolol.
Folgering HT; Borm JF; van Haaren RH
Eur J Clin Pharmacol; 1982 Oct; 23(4):283-8. PubMed ID: 7173299
[TBL] [Abstract][Full Text] [Related]
15. Exercise capacity, energy metabolism, and beta-adrenoceptor blockade. Comparison between a beta 1-selective and a non-selective beta blocker.
Verstappen FT; van Baak MA
Eur J Appl Physiol Occup Physiol; 1987; 56(6):712-8. PubMed ID: 2890520
[TBL] [Abstract][Full Text] [Related]
16. Effects of acute and chronic metoprolol administration during submaximal and maximal exercise.
van Baak MA; Jennen W; Muijtjens A; Verstappen FT
Int J Sports Med; 1985 Dec; 6(6):347-52. PubMed ID: 4077364
[TBL] [Abstract][Full Text] [Related]
17. Controlled release metoprolol formulations. A review of their pharmacodynamic and pharmacokinetic properties, and therapeutic use in hypertension and ischaemic heart disease.
Plosker GL; Clissold SP
Drugs; 1992 Mar; 43(3):382-414. PubMed ID: 1374320
[TBL] [Abstract][Full Text] [Related]
18. Influence of debrisoquine oxidation phenotype on exercise tolerance and subjective fatigue after metoprolol and atenolol in healthy subjects.
Lewis RV; Ramsay LE; Jackson PR; Yeo WW; Lennard MS; Tucker GT
Br J Clin Pharmacol; 1991 Apr; 31(4):391-8. PubMed ID: 2049246
[TBL] [Abstract][Full Text] [Related]
19. Beta-adrenoceptor blockade and hypoglycaemia. A randomised, double-blind, placebo controlled comparison of metoprolol CR, atenolol and propranolol LA in normal subjects.
Kerr D; MacDonald IA; Heller SR; Tattersall RB
Br J Clin Pharmacol; 1990 Jun; 29(6):685-93. PubMed ID: 1974143
[TBL] [Abstract][Full Text] [Related]
20. Differential effects of metoprolol and atenolol to neuropeptide Y blockade in coronary artery disease.
Gullestad L; Pernow J; Bjurö T; Aaberge L; Skårdal R; Kjekshus E; Høglund L; Mellgård AJ; Wahlquist I; Ablad B
Scand Cardiovasc J; 2012 Feb; 46(1):23-31. PubMed ID: 22017530
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
